<SEC-DOCUMENT>0000947871-20-000206-index.html : 20200310
<SEC-HEADER>0000947871-20-000206.hdr.sgml : 20200310
<ACCEPTANCE-DATETIME>20200310170336
ACCESSION NUMBER:		0000947871-20-000206
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200310
DATE AS OF CHANGE:		20200310
GROUP MEMBERS:		ORBIMED CAPITAL GP VI LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CTI BIOPHARMA CORP
		CENTRAL INDEX KEY:			0000891293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911533912
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-48459
		FILM NUMBER:		20702674

	BUSINESS ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 800
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		2062827100

	MAIL ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 800
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELL THERAPEUTICS INC
		DATE OF NAME CHANGE:	19960321

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORBIMED ADVISORS LLC
		CENTRAL INDEX KEY:			0001055951
		IRS NUMBER:				133976876
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		601 LEXINGTON AVENUE
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 739-6400

	MAIL ADDRESS:	
		STREET 1:		601 LEXINGTON AVENUE
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>ss168660_sc13ga.htm
<DESCRIPTION>AMENDMENT NO. 1
<TEXT>
Document 1 - file: ss168660_sc13ga.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>ss168660_ex99a.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ss168660_ex99a.htm

</DOCUMENT>
</SEC-DOCUMENT>